Skip to main content

Passage BIO, Inc.

PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001787297

No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Passage BIO, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of PASG: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders32130−1
Shares1.65M87.4K1.58M+15.9K (+1.0%)
Value$13.2M$702.0K$18.6M+$6.06M (+48.3%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Passage BIO, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to PASG in Q4 2025
InstitutionSharesValue% of portfolio
Eversept Partners, LP126,230$1.49M0.08%
Yiheng Capital Management, L.P.34,301$404.8K0.18%
Northern Trust Corp14,217$167.8K0.00%
Quadrature Capital Ltd12,578$148.4K0.00%
Nano Cap New Millennium Growth Fund L P10,000$118.0K0.10%
Rockefeller Capital Management L.P.500$5.90K0.00%

Sold out (7)

Institutions that held Passage BIO, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of PASG in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Tang Capital Management LLC75,000$602.3K
OrbiMed Advisors LLC59,046$474.1K
Bridgeway Capital Management, LLC20,803$166.6K
Tower Research Capital LLC (TRC)289$2.32K
MAI Capital Management200$1.61K
Citigroup Inc77$617
Northwestern Mutual Wealth Management Co2$16

Not filed for Q4 2025 yet (1)

Institutions that held Passage BIO, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PASG in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
New Leaf Venture Partners, L.L.C.87,426$702.0K